Purchases and Sales Made in Q2 2023 in Erytech Pharma S.A. (ERYP)
This table provides information about the institutional ownership of Erytech Pharma S.A. (ERYP) during Q2 2023. The information is specifically focused on institutions that hold shares of Erytech Pharma S.A..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 11, 2023
Q2 2023
|
Baader Bank Aktiengesellschaft
Unterschleissheim, 2M |
BUY
|
- |
24KNew |
$0 - $29.3K
|
24K
$13K
|
|
|
Aug 11, 2023
Q2 2023
|
Stone X Group Inc.
|
BUY
|
- |
17.3KNew |
$0 - $21.1K
|
17.3K
$9.34K
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
5.8K+ 53.66% |
$0 - $7.07K
|
16.6K
$8.97K
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2023
Q2 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-18.7K- 60.82% |
$0 - $22.9K
|
12.1K
$6.52K
|
|
|
Aug 14, 2023
Q2 2023
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-245K- 98.78% |
$0 - $299K
|
3.02K
$1.63K
|